TriSalus Life Sciences’ SD-101 yields positive outcomes from Phase 1 trial in uveal melanoma with liver metastases

By on    Pharma Industry News  

TriSalus Life Sciences’ SD-101 yields positive outcomes from Phase 1 trial in uveal melanoma with liver metastases

TriSalus Life Sciences made a significant contribution to the Society of Immunotherapy for Cancer (SITC) 2023 Annual Meeting by revealing additional data from its Phase 1 PERIO-01 clinical trial of SD-101. The study, which centers on the treatment of liver metastases from uveal melanoma, utilized the company’s proprietary Pressure-Enabled Drug Delivery (PEDD) with TriNav Infusion […]

280Bio initiates Phase 1 clinical study for YL-17231 after FDA approval

By on    Pharma Industry News  

280Bio initiates Phase 1 clinical study for YL-17231 after FDA approval

In a significant breakthrough for 280Bio, Inc., a clinical-stage biotechnology company, the US Food and Drug Administration (FDA) has given the green light to its Investigational New Drug (IND) application for YL-17231. This investigational drug, a small molecule inhibitor of RAS signaling, will now proceed to Phase 1 clinical study in the U.S. The RAS […]